将尿素引入提拉巴胺衍生物中,以增强抗癌疗法
Yajun Xu1, Jianlin Lv1,2, Chaoying Kong1,2
1Key Laboratory of Polymer Ecomaterials, Changchun Institute of Applied Chemistry, Chinese Academy of Sciences, Changchun 130022, China.
National science review
|March 5, 2024
概括
研究人员开发了新型含尿素的提拉帕扎胺 (TPZ) 衍生物,通过增加缺氧细胞毒性来增强抗癌疗效. 一种针对纤维素的纳米药物配方与血管破坏剂相结合,在临床前模型中显著抑制了瘤生长.
科学领域:
- 在瘤学瘤学.
- 纳米技术 纳米技术
- 药用化学 医学化学
背景情况:
- 低氧激活前药 (HAP) Tirapazamine (TPZ) 显示出抗癌潜力,但由于瘤低氧不足,在试验中缺乏生存益处.
- 提高HAP有效性需要策略来增强瘤缺氧或在缺氧条件下的药物激活.
研究的目的:
- 合成含有尿素的新型TPZ衍生物,提高低毒性细胞毒性和选择性.
- 开发一种纤维素向纳米药物 (FT11-TPZP-NP),以提供高效的药物和减少副作用.
- 在临床前瘤模型中评估FT11-TPZP-NP和CA4-NP的联合治疗效果.
主要方法:
- 含尿素TPZ衍生物的合成和表征.
- 制备纤维素向TPZ装载纳米粒子 (FT11-TPZP-NP).
- 使用FT11-TPZP-NP与CA4-NP (血管破坏剂) 在CT26瘤携带小鼠的组合治疗.
主要成果:
- 与TPZ相比,含尿素的TPZ衍生品呈现出9.5130.85倍的低毒性细胞毒性,保持低毒性选择性.
- 一种衍生品TPZP的细胞毒性比具有类似选择性的TPZ高出20倍.
- 在CT26模型中,FT11-TPZP-NP和CA4-NP的组合实现了98.1%的瘤抑制率,在4/6小鼠中完全消除了瘤.
结论:
- 新型含尿素TPZ衍生物在低氧条件下显著增强抗癌活性.
- 开发的纳米药物输送系统 (FT11-TPZP-NPs) 与CA4-NPs相结合,为改善基于TPZ的抗癌疗法提供了一个有希望的策略.
- 这种方法为增强TPZ和其他低氧激活前药物的治疗疗效提供了新的途径.
相关概念视频
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
165
Endothelins (ETs) are potent vasoactive peptides critical in the human body's various physiological and pathological processes. One of the most promising therapeutic strategies for treating pulmonary arterial hypertension (PAH) involves counteracting the effects of these endothelins using a class of drugs known as endothelin receptor antagonists.
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
165
Parkinson's Disease: Treatment
268
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
268
Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists
288
Dopamine receptor antagonists, also known as antipsychotic agents, are critical in managing chemotherapy-induced vomiting. These antiemetic agents block dopamine receptors in the chemoreceptor trigger zone (CTZ), inhibiting signal transmission to the vomiting center. Antipsychotic agents encompass phenothiazines (PTZ), butyrophenones, benzamides, and thienobenzodiazepines (Zyprexa), which are utilized for their antiemetic and sedative properties.
Phenothiazines, such as prochlorperazine...
Phenothiazines, such as prochlorperazine...
288
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Drugs that Stabilize Microtubules
2.0K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.0K


